Analysts’ Opinions Are Mixed on These Healthcare Stocks: SQZ Biotechnologies (SQZ) and Akebia Therapeutics (AKBA)
05 August 2022 - 09:45PM
TipRanks
Analysts have been eager to weigh in on the Healthcare sector with
new ratings on SQZ Biotechnologies (SQZ – Research Report) and
Akebia Therapeutics (AKBA – Research Report). SQZ Biotechnologies
(SQZ) In a report released today, Geulah Livshits from Chardan
Capital initiated coverage with a Buy rating on SQZ Biotechnologies
and a price target of $17.00. The company's shares closed last
Thursday at $3.24, close to its 52-week low of $2.61. According to
TipRanks.
https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-sqz-biotechnologies-sqz-and-akebia-therapeutics-akba?utm_source=advfn.com&utm_medium=referral
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From May 2023 to Jun 2023
Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
From Jun 2022 to Jun 2023
